PCV79 THE COST-EFFECTIVENESS OF IRBESARTAN IN THE TREATMENT OF HYPERTENSIVE TYPE 2 DIABETIC PATIENTS WITH MICROALBUMINURIA IN CHINA
Abstract
Authors
S Hu W Chen L Annemans
S Hu W Chen L Annemans
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now